"10.1371_journal.pone.0055264","plos one","2013-02-06T00:00:00Z","Attila Szabo; Peter Gogolak; Kitti Pazmandi; Katalin Kis-Toth; Karin Riedl; Benjamin Wizel; Karen Lingnau; Attila Bacsi; Bence Rethi; Eva Rajnavolgyi","Department of Immunology, Medical and Health Science Centre, University of Debrecen, Debrecen, Hungary; Department of Rheumatology, Beth Israel Deaconess Medical Center, Harvard University Medical School Boston, Massachusetts, United States of America; Intercell AG, Vienna, Austria; Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden","Conceived and designed the experiments: ER BR AB PG AS. Performed the experiments: AS PG KP KK BR. Analyzed the data: AS PG KP KK BR. Wrote the paper: AS PG KR BW KL AB BR ER.","KL is an employee of Hoopika Biotech AG. BW is an employee of Johnson & Johnson. KR, BW, and KL were former employees of Intercell AG (Vienna), the original developer and producer of IC31Â®. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials. The other authors state that no conflicting interests exist.","2013","02","Attila Szabo","AS",10,TRUE,5,5,5,8,TRUE,TRUE,FALSE,0,NA,FALSE
